Sameer Mehta  美国佛罗里达州迈阿密大学；介入心脏病学家，主要研究ST段抬高性心肌梗死的直接PCI治疗，建立了SINCERE（Single INdividual Community Experience REgistry for Primary PCI）数据库。

　　<International Circulation>:  In China， although it is well-known that primary PCI has saved many lives， there are still many clinicians who are not yet convinced that they need to do primary PCI. Can you give some indication why physicians should be fighting for primary PCI?

　　《国际循环》：在中国，尽管我们都知道直接PCI挽救了成千上万患者的生命，仍然有很多医生没有认识到直接PCI的重要性。您能谈一谈为什么临床医生需要努力争取进行直接PCI吗？
　　Dr Mehta: The statistics in China are that <5% of patients with an MI are getting a primary PCI done. Whenever you are talking about primary PCI， I think you should immediately differentiate whether you are talking about a primary PCI which occurs at the convenience of the system or a mandated short door-to-balloon time which has a real impact. When you are dealing with that， sooner or later it comes down to how rather than when the Chinese physicians will figure out that: firstly， a STEMI intervention is probably one of the best indications for PCI which truly makes a difference to the patient’s long-term outcomes; and secondly， that if they have to do it， it is not a matter of trusting a system that is in its stages of infancy and development， but to quickly proceed with a STEMI intervention. Having said that， I think this is where Doctor Yang， who uses Chinese PCI studies of such paramount importance. They will prepare the nation for a statewide system where early STEMI intervention will occur in a very cost-effective manner. One of the things that is holding back the Chinese profession is the cost involved and particularly in this study where you have a preferred bare-metal stent， I think that will drive a strategy where there will be a cost-effective bare-metal stent with some form of thrombectomy which makes a difference， in addition to an early door-to-balloon environment across the nation.

    直接PCI应用的必要性
    无论何时，谈到直接PCI，我认为我们应该立即区分出我们讨论的是在绿色通道进行的直接PCI还是有实际作用的规范的快速入院至球囊扩张时间。在处理这些情况的时候，我们必须强调：首先，急性ST段抬高性心肌梗死（STEMI）的介入治疗可能是PCI最好的指征，这种情况下进行PCI能真正改善患者的远期预后；其次，如果患者需要进行PCI，那么信任一个介入治疗处于刚刚起步并正在发展的医疗单位并不是问题，快速对STEMI患者进行介入治疗才是关键。